Oral Contraceptives in the Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2018
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 07 Jun 2018 Status changed from active, no longer recruiting to completed.
- 12 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
- 10 Jun 2017 Biomarkers information updated